Glass House Brands Inc. GLAS
i
Market datapartial · fetched 2026-11-11T13:44:41.266Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T13:13:07.346459366Z
FundamentalsAlpha Vantage · unavailable
Glass House Brands Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 2.07 | 178.4% | 11.0% | |||
| 50Δ | 2.16 | 183.8% | 9.8% | |||
| 55Δ | 2.16 | 298.4% | 22.7% | 2.26 | 189.2% | 8.6% |
| 60Δ | 2.03 | 301.5% | 18.5% | |||
| 65Δ | 1.91 | 292.4% | 15.3% | |||
| 70Δ | 1.80 | 279.9% | 12.3% | |||
| 75Δ | 1.69 | 267.4% | 9.4% | |||
| 80Δ | 1.58 | 254.9% | 6.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.07
- IV
- 178.4%
- B/E move
- 11.0%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.16
- IV
- 183.8%
- B/E move
- 9.8%
55Δ
- Pseudo strike
- 2.16
- IV
- 298.4%
- B/E move
- 22.7%
- Pseudo strike
- 2.26
- IV
- 189.2%
- B/E move
- 8.6%
60Δ
- Pseudo strike
- 2.03
- IV
- 301.5%
- B/E move
- 18.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.91
- IV
- 292.4%
- B/E move
- 15.3%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.80
- IV
- 279.9%
- B/E move
- 12.3%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 1.69
- IV
- 267.4%
- B/E move
- 9.4%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.58
- IV
- 254.9%
- B/E move
- 6.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 161.65% | |
| 111.32% | |
| 157.62% | |
| 164.11% | |
| 174.71% | |
| 193.47% | |
| 206.07% | |
| 144.86% | |
| 156.16% | |
| 163.83% |
Drug Manufacturers - Specialty & Generic
HCM
HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central,…
More →HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San…
More →HLN
Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline, dedicated to providing innovative health solutions through a robust…
More →HROW
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
More →INCR
Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America,…
More →IRWD
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston,…
More →